These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 35579429)

  • 1. Increased Abundance of Achromobacter xylosoxidans and Bacillus cereus in Upper Airway Transcriptionally Active Microbiome of COVID-19 Mortality Patients Indicates Role of Co-Infections in Disease Severity and Outcome.
    Devi P; Maurya R; Mehta P; Shamim U; Yadav A; Chattopadhyay P; Kanakan A; Khare K; Vasudevan JS; Sahni S; Mishra P; Tyagi A; Jha S; Budhiraja S; Tarai B; Pandey R
    Microbiol Spectr; 2022 Jun; 10(3):e0231121. PubMed ID: 35579429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral infectious diseases severity: co-presence of transcriptionally active microbes (TAMs) can play an integral role for disease severity.
    Yadav A; Pandey R
    Front Immunol; 2022; 13():1056036. PubMed ID: 36532032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory Co-Infections: Modulators of SARS-CoV-2 Patients' Clinical Sub-Phenotype.
    Mehta P; Sahni S; Siddiqui S; Mishra N; Sharma P; Sharma S; Tyagi A; Chattopadhyay P; Vivekanand A; Devi P; Khan A; Waghdhare S; Budhiraja S; Uppili B; Maurya R; Nangia V; Shamim U; Hazarika PP; Wadhwa S; Tyagi N; Dewan A; Tarai B; Das P; Faruq M; Agrawal A; Jha S; Pandey R
    Front Microbiol; 2021; 12():653399. PubMed ID: 34122366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metagenomic Next-Generation Sequencing of Nasopharyngeal Specimens Collected from Confirmed and Suspect COVID-19 Patients.
    Mostafa HH; Fissel JA; Fanelli B; Bergman Y; Gniazdowski V; Dadlani M; Carroll KC; Colwell RR; Simner PJ
    mBio; 2020 Nov; 11(6):. PubMed ID: 33219095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metagenomic next-generation sequencing of nasopharyngeal microbiota in COVID-19 patients with different disease severities.
    Aljabr W; Dandachi I; Abbas B; Karkashan A; Al-Amari A; AlShahrani D
    Microbiol Spectr; 2024 May; 12(5):e0416623. PubMed ID: 38557102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptionally active nasopharyngeal commensals and opportunistic microbial dynamics define mild symptoms in the COVID 19 vaccination breakthroughs.
    Devi P; Kumari P; Yadav A; Tarai B; Budhiraja S; Shamim U; Pandey R
    PLoS Pathog; 2023 Feb; 19(2):e1011160. PubMed ID: 36800345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Super Dominant Pathobiontic Bacteria in the Nasopharyngeal Microbiota Cause Secondary Bacterial Infection in COVID-19 Patients.
    Qin T; Wang Y; Deng J; Xu B; Zhu X; Wang J; Zhou H; Zhao N; Jin F; Ren H; Wang H; Li Q; Xu X; Guo Y; Li R; Xiong Y; Wang X; Guo J; Zheng H; Hou X; Wan K; Zhang J; Lu J; Kan B; Xu J
    Microbiol Spectr; 2022 Jun; 10(3):e0195621. PubMed ID: 35579467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity, composition, and networking of saliva microbiota distinguish the severity of COVID-19 episodes as revealed by an analysis of 16S rRNA variable V1-V3 region sequences.
    Larios Serrato V; Meza B; Gonzalez-Torres C; Gaytan-Cervantes J; González Ibarra J; Santacruz Tinoco CE; Anguiano Hernández YM; Martínez Miguel B; Cázarez Cortazar A; Sarquiz Martínez B; Alvarado Yaah JE; Mendoza Pérez AR; Palma Herrera JJ; García Soto LM; Chávez Rojas AI; Bravo Mateos G; Samano Marquez G; Grajales Muñiz C; Torres J
    mSystems; 2023 Aug; 8(4):e0106222. PubMed ID: 37310423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.
    Merenstein C; Liang G; Whiteside SA; Cobián-Güemes AG; Merlino MS; Taylor LJ; Glascock A; Bittinger K; Tanes C; Graham-Wooten J; Khatib LA; Fitzgerald AS; Reddy S; Baxter AE; Giles JR; Oldridge DA; Meyer NJ; Wherry EJ; McGinniss JE; Bushman FD; Collman RG
    mBio; 2021 Aug; 12(4):e0177721. PubMed ID: 34399607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 infection predisposes patients to coinfection with
    Lubkin A; Bernard-Raichon L; DuMont AL; Valero Jimenez AM; Putzel GG; Gago J; Zwack EE; Olusanya O; Boguslawski KM; Dallari S; Dyzenhaus S; Herrmann C; Ilmain JK; Isom GL; Pawline M; Perault AI; Perelman S; Sause WE; Shahi I; St John A; Tierce R; Zheng X; Zhou C; Noval MG; O'Keeffe A; Podkowik M; Gonzales S; Inglima K; Desvignes L; Hochman SE; Stapleford KA; Thorpe LE; Pironti A; Shopsin B; Cadwell K; Dittmann M; Torres VJ
    mBio; 2024 Aug; 15(8):e0166724. PubMed ID: 39037272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duplex real-time PCR assay for the simultaneous detection of
    Price EP; Soler Arango V; Kidd TJ; Fraser TA; Nguyen TK; Bell SC; Sarovich DS
    Microb Genom; 2020 Jul; 6(7):. PubMed ID: 32667877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical outcome of COVID-19 is strongly associated with microbiome dynamics in the upper respiratory tract.
    Xie L; Luo G; Yang Z; Wu WC; Chen J; Ren Y; Zeng Z; Ye G; Pan Y; Zhao WJ; Chen YQ; Hou W; Sun Y; Guo D; Yang Z; Li J; Holmes EC; Li Y; Chen L; Shi M
    J Infect; 2024 Mar; 88(3):106118. PubMed ID: 38342382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 infection severity and mortality is modulated by repeat-mediated regulation of alternative splicing.
    Mehta P; Chattopadhyay P; Ravi V; Tarai B; Budhiraja S; Pandey R
    Microbiol Spectr; 2023 Aug; 11(5):e0135123. PubMed ID: 37604131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual RNA-Seq reveals transcriptionally active microbes (TAMs) dynamics in the serum of dengue patients associated with disease severity.
    Yadav A; Kumari P; Devi P; Adjele JJB; Budhiraja S; Tarai B; Pandey R
    Front Microbiol; 2023; 14():1307859. PubMed ID: 38107870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic and phylogenetic analysis of multidrug-resistant Achromobacter xylosoxidans ST273 strain MTYH1 co-carrying bla
    Zhu Z; Xu J; He F
    J Glob Antimicrob Resist; 2021 Jun; 25():110-113. PubMed ID: 33766786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients.
    de Castilhos J; Zamir E; Hippchen T; Rohrbach R; Schmidt S; Hengler S; Schumacher H; Neubauer M; Kunz S; Müller-Esch T; Hiergeist A; Gessner A; Khalid D; Gaiser R; Cullin N; Papagiannarou SM; Beuthien-Baumann B; Krämer A; Bartenschlager R; Jäger D; Müller M; Herth F; Duerschmied D; Schneider J; Schmid RM; Eberhardt JF; Khodamoradi Y; Vehreschild MJGT; Teufel A; Ebert MP; Hau P; Salzberger B; Schnitzler P; Poeck H; Elinav E; Merle U; Stein-Thoeringer CK
    Clin Infect Dis; 2022 Aug; 75(1):e1063-e1071. PubMed ID: 34694375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring nasopharyngeal microbiota profile in children affected by SARS-CoV-2 infection.
    Romani L; Del Chierico F; Pane S; Ristori MV; Pirona I; Guarrasi V; Cotugno N; Bernardi S; Lancella L; Perno CF; Rossi P; Villani A; Campana A; Palma P; Putignani L;
    Microbiol Spectr; 2024 Mar; 12(3):e0300923. PubMed ID: 38289047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic characterization of the dominating Beta, V2 variant carrying vaccinated (Oxford-AstraZeneca) and nonvaccinated COVID-19 patient samples in Bangladesh: A metagenomics and whole-genome approach.
    Rahaman MM; Sarkar MMH; Rahman MS; Islam MR; Islam I; Saha O; Akter S; Banu TA; Jahan I; Habib MA; Goswami B; Bari L; Malek MA; Khan MS
    J Med Virol; 2022 Apr; 94(4):1670-1688. PubMed ID: 34939673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metatranscriptomic Analysis Reveals Disordered Alterations in Oropharyngeal Microbiome during the Infection and Clearance Processes of SARS-CoV-2: A Warning for Secondary Infections.
    Zhou Y; Lu S; Wei X; Hu Y; Li H; Wang J; Lin Y; Li M; Wang M; Ma J; Zhu Z; Yang S; Ying B; Zhang W; Chen B; Li W
    Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.